Genetic Technologies Ltd Capital Reinvestment Ratio
Genetic Technologies Ltd capital reinvestment ratio. Genetic Technologies Ltd (GENE) has a Capital Reinvestment Ratio of 0.06x as of June 2011, meaning it reinvests 0% of its operating cash flow ($1.12 Million) in capital expenditures ($69.84K). Check Genetic Technologies Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Genetic Technologies Ltd (2007–2011)
Capital reinvestment ratio of Genetic Technologies Ltd from 2007 to 2011. This chart tracks Genetic Technologies Ltd's Capital Reinvestment Ratio across 3 annual periods. Also explore GENE net asset momentum to track the company's year-over-year net asset growth rate.
Genetic Technologies Ltd Capital Reinvestment Ratio by Year (2007–2011)
Genetic Technologies Ltd capital reinvestment ratio by year from 2007 to 2011. For the full cash flow conversion analysis, see GENE cash flow metrics.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2011 | 0.06x | $2.23 Million | $139.68K | ▼ -77.6% |
| 2008 | 0.28x | $423.68K | $118.26K | ▲ +286.6% |
| 2007 | 0.07x | $2.20 Million | $158.87K | — |